Skip to content

Study on the Efficacy and Safety of an Insulin Dose Decision Support System in Intensive Insulin Therapy for Hospitalized Diabetic Patients

Study on the Efficacy and Safety of an Insulin Dose Decision Support System in Intensive Insulin Therapy for Hospitalized Diabetic Patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500102505
Enrollment
Unknown
Registered
2025-05-15
Start date
2025-05-20
Completion date
Unknown
Last updated
2025-05-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus

Interventions

study group:System-generated insulin dose recommendations must be strictly implemented within predefined safety thresholds. If the recommendations exceed these thresholds, physicians may adjust the do
control group:No

Sponsors

Changhai Hospital, Shanghai
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1.Hospitalized patients aged 18–75 years; 2.Patients diagnosed with diabetes requiring intensive insulin therapy; 3.Patients with poorly controlled blood glucose (e.g., significant glycemic variability or failure to meet glycemic targets) and HbA1c >=8.0%.

Exclusion criteria

Exclusion criteria: 1.History of severe insulin allergy; 2.Women who are planning pregnancy, pregnant, or breastfeeding; 3.Severe comorbidities, including but not limited to: end-stage renal disease, hepatic failure, cardiovascular diseases, cerebrovascular diseases, or severe diabetes-related complications; 4.Patients with psychiatric disorders or mental abnormalities; 5.Any other conditions deemed unsuitable for participation by the investigators.

Design outcomes

Primary

MeasureTime frame
Time to Glycemic Target Achievement;

Secondary

MeasureTime frame
Glycemic Target Attainment;Incidence of Hypoglycemic Events;

Countries

China

Contacts

Public ContactLu Jin

Changhai Hospital, Shanghai

www.498039781@qq.com+86 134 8271 7798

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026